Clinical Advances in Management of Lung Cancer
CLINICAL ADVANCES IN Management of Lung Cancer
Supported by an independent educational grant from F. Hoffman-La Roche Ltd.
New Resources are now available from Medscape Education’s Clinical Advances in The Management of Lung Cancer.
NEW Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC
Are you staying up to date on the latest practice-changing data revolutionizing the treatment for lung cancer?
Advances in Lung Cancer Management
Face off against your colleagues in a fast-paced series of medical questions about lung cancer! Deepen knowledge, have fun, and grapple for the number 1 spot on the leaderboard.
Related Resources
Access relevant clinical articles, guidelines, and downloadable slides.
Clinical Advances in The Management of Lung Cancer is a thematic curriculum for physicians, dedicated to improving the management of patients with lung cancer.
| Learn More |
Steering Committee
| Solange Peters, MD, PhD Steering Committee Chair Professor of Oncology Medical Oncology Chair Lausanne University Hospital Lausanne, Switzerland |
| Enriqueta Felip, MD, PhD Medical Oncologist Head, Thoracic Malignancies Vall d'Hebron University Hospital Barcelona, Spain |
| Stephen Liu, MD Associate Professor of Medicine Director of Thoracic Oncology Director of Developmental Therapeutics Lombardi Comprehensive Cancer Center Georgetown University Washington, DC, United States |
| Martin Reck, MD Professor of Medicine Department of Thoracic Oncology LungenClinic Großhansdorf Großhansdorf, Germany |
| Sanjay Popat, PhD, FRCP Professor of Thoracic Oncology Institute of Cancer Research Consultant Medical Oncologist The Royal Marsden Hospital London, United Kingdom |
| Debra Montague President, Lung Cancer Europe (LuCE) Chair, ALK Positive Lung Cancer UK Caldicot, United Kingdom |